AC Immune (ACIU) Shareholder's Equity Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.59% |
| Sep 30, 2025 | -26.52% |
| Jun 30, 2025 | -24.60% |
| Mar 31, 2025 | -23.10% |
| Dec 31, 2024 | -20.14% |
| Sep 30, 2024 | -90.84% |
| Jun 30, 2024 | -91.30% |
| Mar 31, 2024 | -91.03% |
| Dec 31, 2023 | -8.75% |
| Sep 30, 2023 | -17.50% |
| Jun 30, 2023 | -15.88% |
| Mar 31, 2023 | -15.56% |
| Dec 31, 2022 | -13.95% |
| Sep 30, 2022 | -12.80% |
| Jun 30, 2022 | 817.60% |
| Mar 31, 2022 | -1.53% |
| Dec 31, 2021 | 12.12% |
| Dec 31, 2020 | 26.26% |
| Sep 30, 2020 | 19.63% |
| Jun 30, 2020 | 21.67% |
| Mar 31, 2020 | 27.49% |
| Dec 31, 2019 | 24.58% |
| Sep 30, 2019 | 26.68% |
| Jun 30, 2019 | -87.71% |
| Mar 31, 2019 | 29.73% |
| Dec 31, 2018 | 35.47% |
| Dec 31, 2017 | 69.43% |